Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-28T05:39:32.050Z Has data issue: false hasContentIssue false

Longitudinal predictors of subjective recovery in psychosis

Published online by Cambridge University Press:  02 January 2018

Heather Law*
Affiliation:
Greater Manchester West Mental Health NHS Foundation Trust, Manchester
Nick Shryane
Affiliation:
University of Manchester
Richard P. Bentall
Affiliation:
University of Liverpool
Anthony P. Morrison
Affiliation:
Greater Manchester West Mental Health NHS Foundation Trust, Manchester, UK
*
Heather Law, Greater Manchester West Mental Health NHS Foundation Trust, Rico House c/o Harrop House, Bury New Road, Prestwich, Manchester M25 3BL, UK. Email: heather.law@gmw.nhs.uk
Rights & Permissions [Opens in a new window]

Abstract

Background

Research has highlighted the importance of recovery as defined by the service user, and suggests a link to negative emotion, although little is known about the role of negative emotion in predicting subjective recovery.

Aims

To investigate longitudinal predictors of variability in recovery scores with a focus on the role of negative emotion.

Method

Participants (n=110) with experience of psychosis completed measures of psychiatric symptoms, social functioning, subjective recovery, depression, hopelessness and self-esteem at baseline and 6 months later. Path analysis was used to examine predictive factors for recovery and negative emotion.

Results

Subjective recovery scores were predicted by negative emotion, positive self-esteem and hopelessness, and to a lesser extent by symptoms and functioning. Current recovery score was not predicted by past recovery score after accounting for past symptoms, current hopelessness and current positive self-esteem.

Conclusions

Psychosocial factors and negative emotion appear to be the strongest longitudinal predictors of variation in subjective recovery, rather than psychiatric symptoms.

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 2016 

Recovery in psychosis has traditionally been defined within a biomedical framework based on symptom remission, decreased hospital admissions or relapse, 1 or operationally defined as a return to functioning in the normal range. Reference Torgalsboen2 These approaches to understanding and defining recovery have received criticism in recent years for not taking into account the ‘consumer’ perspective. Reference Bellack3 People using mental health services define recovery as a personal journey or process, Reference Deegan4,Reference Pitt, Kilbride, Nothard, Welford and Morrison5 often characterised by themes including hope, empowerment and social support. Reference Deegan4Reference Ridgeway8 Recent cross-sectional research has investigated factors associated with subjective recovery and improved quality of life, demonstrating a significant role for psychosocial factors including negative emotion. Reference Morrison, Shyrane, Beck, Heffernan, Law and McCusker9 However, little is known about the role of negative emotion and psychosocial factors in predicting subjective recovery or variation in subjective recovery scores over time. Our longitudinal study aimed to investigate predictors of subjective recovery, with a particular focus on the role of negative emotion; based on an a priori theoretical model, our hypothesis was that recovery scores at 6 months would be predicted by recovery score and negative emotion at baseline.

Method

A convenience sample of participants was recruited from early intervention teams, community mental health teams, in-patient settings and voluntary services across the north-west of England. Participants were included in the data-set if they were aged 16–65 years, had a diagnosis of schizophrenia spectrum disorder, had sufficient understanding of the English language to allow them to complete the measures and had the capacity to provide informed consent. A total of 174 participants were assessed at baseline and 171 participants were assessed at the 6-month follow-up point. The average age of participants was 37.3 years (s.d. = 11.62) and the majority of participants were White British (83.6%). Diagnoses at referral were schizophrenia (n = 50), schizoaffective disorder (n = 13), persistent delusional disorder (n = 7), unspecified non organic psychosis (n = 4) and acute and transient psychotic disorder (n = 2). The remaining 30 participants had not been given a diagnosis but were experiencing psychosis. Participants were recruited from early intervention services (n = 27), community-based mental health teams (n = 45) and an in-patient service (n = 1). Data on service type at referral were missing for 37 participants.

Measures

Questionnaire about the Process of Recovery

The Questionnaire about the Process of Recovery (QPR) is a self-report measure which was developed collaboratively by a team of service user researchers and clinicians. Reference Neil, Kilbride, Pitt, Nothard, Welford and Sellwood10,Reference Law, Neil, Dunn and Morrison11 Items are rated on a five-point Likert scale ranging from ‘strongly disagree’ to ‘strongly agree’. Reference Deegan4 Higher scores on the measure are indicative of subjective recovery. The brief 15-item version of the QPR was used in this study. Reference Law, Neil, Dunn and Morrison11 Cronbach's alpha for our sample was 0.947. Examples of the highest-loading items in the QPR include ‘I can actively engage with life’, ‘I can take charge of my life’ and ‘I feel part of society rather than isolated’. The QPR measures specific, recovery-related emotional constructs and so was expected to be strongly related with general measures of emotional functioning. They are not the same, however; using confirmatory factor analysis, Morrison et al found recovery beliefs measured by the QPR to be empirically distinct from general negative emotion (i.e. anxiety, depression and negative self-esteem) in a sample of psychiatric patients diagnosed with schizophrenia spectrum disorder. Reference Morrison, Shyrane, Beck, Heffernan, Law and McCusker9

Positive and Negative Syndrome Scale

The Positive and Negative Syndrome Scale (PANSS) is a 30-item semi-structured clinical interview comprising 7 items assessing positive symptoms (such as hallucinations and delusions), 7 assessing negative symptoms (such as blunted affect and emotional withdrawal) and 16 assessing global psychopathology (such as anxiety, guilt and depression). Reference Kay, Fiszbein and Opler12 All items are rated from 1 (not present) to 7 (severe). The PANSS has been used in a variety of studies and has been shown to have good reliability and validity. Reference Kay, Opler and Lindenmayer13

Personal and Social Performance

The Personal and Social Performance (PSP) scale is a measure of functioning rated by an observer across four domains: socially useful activities, personal and social relationships, self-care and aggression. Reference Morosini, Magliano, Brambilla, Ugolini and Pioli14 The scale has been shown to have adequate internal consistency (α = 0.76). Reference Kawata and Revicki15 Total scores range from 1 to 100, with 100 indicating no functional difficulty. Most participants were rated for functioning using this scale, but a few (n = 27) were rated instead with the functioning subscale of the Global Assessment of Functioning (GAF), Reference Hall16 another measure of functioning that is used by an observer to rate symptoms and social, psychological and occupational functioning. Again, scores range from 1 to 100, with 100 representing no functional difficulty.

Calgary Depression Scale for Schizophrenia

The Calgary Depression Scale for Schizophrenia (CDSS) comprises 9 items each rated on a three-point Likert scale. Reference Addington, Addington and Schissel17 Global scores range from 0 to 27. The scale measures items on depression, hopelessness, self-depreciation, guilty ideas of reference, pathological guilt, morning depression, early wakening, suicide and observed depression.

Beck Hopelessness Scale

The Beck Hopelessness Scale (BHS) is a 20-item self-report measure designed by clinicians to measure three dimensions of hopelessness: feelings about the future, loss of motivation and expectations. Reference Beck, Weissman, Lester and Trexler18 Statements are rated by participants as true or false for their attitudes over the past week. The psychometric properties of the BHS have been examined in various studies and the measure has shown good reliability and validity. Reference Nunn, Lewin, Walton and Carr19Reference Young, Halper, Clark, Scheftner and Fawcett21

Self Esteem Rating Scale

The short form of the Self Esteem Rating Scale (SERS) is a 20-item self-report measure assessing both positive and negative beliefs about the self. Reference Lecomte, Corbiere and Laisne22 Items are rated on a seven-point Likert scale ranging from ‘never’ to ‘always’. The scale demonstrated good internal consistency and reliability and adequate convergent validity. Reference Lecomte, Corbiere and Laisne22

Procedure

Data were collected as part of a programme of research funded by the UK National Institute of Health Research. Individual studies within this research programme were approved by the research ethics committee involved. Recruitment took place across early intervention teams, community mental health teams, in-patient settings and voluntary services across the Greater Manchester area to ensure heterogeneity of service provision and experience of psychosis. Potential participants were approached by the care team and offered information about the study. Interested participants were given a minimum of 24 h to read the participant information sheet and decide whether to take part. Those who agreed to do so met with a researcher to complete a consent form and baseline study measures. The researcher then contacted participants 6 months later to repeat the set of measures in a follow-up assessment. Participants were recompensed for their time.

Statistical analysis

Path analysis was conducted to examine potential predictors of recovery scores and negative emotion. All path models were fitted in Mplus version 7 and estimated by maximum likelihood. Standard errors were estimated using the Huber–White sandwich estimator, which is robust to non-normality and heteroscedasticity in the outcome variables. Model log-likelihoods and the likelihood ratio tests were computed using Satorra–Bentler adjustments for non-normality. Nested models were compared using Satorra–Bentler corrected likelihood ratio chi-squared tests. Data from 110 participants who completed all measures in the model were included in the final path analysis. Data from 64 participants were excluded owing to missing or incomplete data-sets; these participants were not significantly different at baseline assessment from those who were included in the final analysis. The path analysis models were based on over 200 observations.

Model variables

Variables were assessed at baseline (time 1) and at 6-month follow-up (time 2). The sample was too small for adequate latent constructs; instead, scale composites were constructed to represent symptoms of psychosis (based on PANSS scores) and negative emotions (based on negative self-esteem and the Calgary scale). Reliability was generally good for these composites: PANSS α = 0.84 (time 1 only, α = 0.75; time 2 only, α = 0.73); negative emotions α = 0.82 (time 1 only, α = 0.72; time 2 only, α = 0.60). The reliability for negative emotion at time 2 was low. However, this reliability was based on just two items and was therefore considered acceptable. Core variables were recovery and negative emotion. Recovery consisted of the 15-item total QPR score. Negative emotion was a composite variable constructed by taking the mean of scores from the CDSS and the SERS negative subscale. The latter is scored from 10 to 70 whereas the CDSS is scored from 0 to 27. To avoid the composite measure being dominated by the higher scores of the SERS subscale, its raw scores were divided by 7 before taking the composite mean, which gave both contributing scales similar means and standard deviations.

Test variables included symptoms, hopelessness, positive self-esteem and functioning. Symptoms consisted of a composite variable representing the overall mean of the 7 positive, 7 negative and 16 general PANSS scale items. Hopelessness used the total score from the BHS. Positive self-esteem used the total score from the positive subscale of the SERS. Functioning used the functioning score of the PSP scale if available and the functioning subscale of the GAF if not. For the small number of participants (n = 34) who completed both the GAF and the PSP in this study, the correlation between these variables was impressive (r = 0.79). This is congruent for the theoretical expectations for these scales, with previous research suggesting a high correlation between GAF and PSP scores. Reference Juckel and Morosini23

Exogenous covariates measured at time 1 included age, education or employment, marital status, religious beliefs and early intervention. All covariates except age were binary variables coded as 1 for a positive response (i.e. in education or employment; married or living with a common-law spouse; belief in the existence of a deity; and recruitment from an early intervention service) and 0 for a negative response. These covariates were included to allow consideration of the effects of demographic and other potential confounding factors that were available within the data-set.

Results

Demographic characteristics of the sample are shown in Table 1. Table 2 summarises participants' scores from the baseline and 6-month follow-up assessments.

Table 1 Participant characteristics (n = 110)

Variable % n
Gender
    Male 69 76
    Female 31 34
Ethnicity
    White 84 92
    Asian 8 9
    Black 5 5
    Mixed 4 4
Marital status
    Single 78 86
    Married 11 12
    Separated 11 12
Employment status
    Employed 7 8
    Unemployed 76 84
    Student 3 3
    Volunteer 10 11
    Retired 4 4
Religious belief
    None 35 39
    Christian 32 35
    Muslim 11 12
    Other 22 24

Table 2 Participant scores for key measures at baseline and 6-month follow-up

Baseline 6-month follow-up
n Score
mean (s.d.)
n Score
mean (s.d.)
GAF functioning 61 44.72 (10.73) 57 46.98 (12.98)
PSP 147 63.63 (16.71) 148 85.43 (121.62)
PANSS positive 174 13.64 (4.63) 171 12.37 (4.32)
PANSS negative 174 12.42 (3.65) 171 11.84 (3.78)
PANSS general 110 27.78 (6.91) 108 25.10 (7.09)
Calgary depression 125 6.09 (4.67) 125 4.48 (4.26)
QPR 15-item total 173 47.46 (12.39) 170 56.65 (11.55)
BHS total 166 8.49 (5.96) 122 8.22 (5.31)
SERS positive 173 39.70 (13.46) 121 40.35 (13.42)
SERS negative 173 36.11 (14.64) 121 34.35 (14.34)

BHS, Beck Hopelessness Scale; GAF, Global Assessment of Functioning; PANSS, Positive and Negative Syndrome Scale; PSP, Personal and Social Performance; QPR, Questionnaire about the Process of Recovery; SERS, Self Esteem Rating Scale.

Model of recovery and negative emotion

Recovery and negative emotion were highly correlated at each time point (r = −0.66 in both). These core constructs were entered into a cross-lagged autoregressive model, as shown in Fig. 1, which for simplicity does not show these within time-point correlations. Table 3 shows the parameter estimates for this model. Both recovery and negative emotion at time 1 were significant predictors of recovery at time 2, but only negative emotion at time 1 was a significant predictor of negative emotion at time 2. The R 2 value for recovery at time 2 was 31.8% and for negative emotion at time 2 was 58.3%. The large R 2 for negative emotion at time 2 was mainly accounted for by its relationship with negative emotion at the previous time point.

Fig. 1 Path diagram of core model (model 1) showing standardised regression coefficients (bold type indicates significance at P<0.05).

Rec, recovery; Nemo, negative emotion; suffix indicates time 1 or 2.

Table 3 Parameter estimates for core model of recovery and negative emotion (n = 110)

B SE P Beta
Predictor of recovery at time 2
    Recovery at time 1 0.26 0.08 0.001 0.35
    Negative emotion at time1 −0.85 0.31 0.006 −0.27
Predictor of negative emotion at time 2
    Recovery at time 1 −0.02 0.02 0.213 −0.09
    Negative emotion at time 1 0.64 0.07 <0.001 0.70

SE, standard error.

Further development and testing of the model

The influence of the test variables on negative emotion and recovery was evaluated by comparing the core model of recovery and negative emotion above with each of the test models (models 2.1–2.4) described below. The fit of these nested models was formally compared using Satorra–Bentler corrected likelihood ratio chi-squared tests. In each test model the core model was added to by including extra predictors of the outcome variables (recovery and negative emotion at time 2). In the first test model (2.1) overall PANSS symptom scores at times 1 and 2 were added as additional predictors. In model 2.3 the extra predictors were the hopelessness scores at time 1 and time 2. Positive self-esteem was the extra predictor in model 2.3 and functioning was included in model 2.4. The results of the likelihood ratio tests comparing each of models 2.1–2.4 with the core model can be found in online Table DS1. All models improved significantly on the fit of the core model, with the largest improvements seen in the prediction of recovery scores at time 2 due to hopelessness and positive self-esteem.

A final model was then fitted, which combined the predictors that were tested separately in models 2.1–2.4 into a single model, 2.5 (Fig. 2); the parameter estimates for this model are shown in Table 4. Recovery at time 2 was predicted by symptoms at time 1 and hopelessness and positive self-esteem at time 2. After accounting for these influences, recovery at time 1 was no longer a significant predictor of recovery at time 2. Negative emotion at time 1 was a significant predictor of negative emotion at time 2, along with symptoms, hopelessness and positive self-esteem at time 2.

Fig. 2 Path diagram of model 2.5, showing standardised regression coefficients (bold type indicates significance at P<0.05).

Func, functioning; Hope, hopelessness; Nemo, negative emotion; PANSS, Positive and Negative Syndrome Scale; Rec, recovery; SE, self-esteem (suffix indicates time 1 or time 2).

Table 4 Parameter estimates for full model (model 2.5) (n = 110)

B SE P Beta
Predictor of recovery at T 2
    Recovery T 1 0.01 0.08 0.94 0.01
    Negative emotion T 1 −0.09 0.38 0.81 −0.03
    PANSS score T 1 −3.49 1.56 0.03 −0.17
    Hopelessness T 1 −0.18 0.13 0.17 −0.11
    Positive self-esteem T 1 0.00 0.07 0.98 0.00
    Functioning T 1 −0.09 0.06 0.12 −0.1
    PANSS score T 2 −0.32 2.38 0.89 −0.01
    Hopelessness T 2 −0.50 0.14 0.00 −0.26
    Positive self-esteem T 2 0.24 0.06 0.00 0.33
    Functioning T 2 0.14 0.07 0.05 0.23
Predictor of negative emotion at T 2
    Recovery T 1 0.00 0.02 0.93 −0.01
    Negative emotion T 1 0.57 0.07 0.00 0.63
    PANSS score T 1 −0.57 0.47 0.22 −0.09
    Hopelessness T 1 −0.03 0.04 0.40 −0.07
    Positive self-esteem T 1 0.02 0.02 0.26 0.09
    Functioning T 1 −0.01 0.01 0.68 −0.03
    PANSS score T 2 1.46 0.62 0.02 0.21
    Hopelessness T 2 0.11 0.04 0.01 0.20
    Positive self-esteem T 2 −0.04 0.02 0.02 −0.19
    Functioning T 2 0.00 0.02 0.99 0.00

PANSS, Positive and Negative Syndrome Scale; SE, standard error; T 1, time 1 (baseline); T 2, time 2 (follow-up).

Checking for endogeneity

There was a possibility that regressing closely related constructs upon one another within each data collection time point would be stretching assumptions of exogeneity with regard to these constructs. To test for this we ran an additional model, 2.6, which regressed recovery and negative emotion at time 2 on the other variables from time 1 only, not including the other time 2 variables as predictors. Symptoms and positive self-esteem at time 1 were significant predictors of recovery beliefs at time 2, each with broadly equal magnitude (online Table DS2). These predictors accounted for 44% of the variance in recovery at time 2. By far the strongest predictor of negative emotion at time 2 is the time 1 score on this variable. No other time 1 variable was a significant predictor of negative emotion at time 2 (R 2 = 61%). The fact that recovery and negative emotion have different sets of predictors is evidence in support of the fact that these are distinct constructs.

Confounding

In the previous analyses no attempt was made to control for the effects of demographic and other potentially confounding factors. Such variables available in this study were age, gender, marital status, employment status, religious beliefs and whether the participant was recruited from an early intervention or other service. We therefore fitted the same series of models above, but this time regressed the outcome variables (i.e. recovery and negative emotion at time 2) on these covariates. The pattern of model improvement was identical to that seen in Table 4, and the only significant potential confounder variable was gender. We decided to fit a final model exploiting the fact that we could plausibly assume that gender was a truly exogenous variable and so include it as a predictor of both the time 1 and time 2 outcomes. The results for this model (M3) are shown in online Table DS3. The pattern of significant results in model 3 is identical to that in model 2.6 with the notable addition that gender is a significant and substantial predictor of recovery score at time 2, with men having an average recovery score four points less than women. This is despite the fact that gender was a significant predictor neither of recovery at time 1 nor of negative emotion at either time point. It was not simply the case that one of these gender effects had reached significance and the other had not – a test of the difference between the effects of gender on recovery between time 1 and time 2 was also significant (P<0.01).

Discussion

Subjective recovery scores at time 2 were predicted by negative emotion, positive self-esteem and hopelessness, and to a lesser extent by symptoms and functioning at time 1. Additionally, current recovery score was predicted by current hopelessness and positive self-esteem. Current recovery score was not predicted by past recovery scores after accounting for past symptoms and current hopelessness and positive self-esteem. The strongest predictor of negative emotion was past negative emotion, suggesting a trait-like interpretation. Other predictors of negative emotion included current scores for symptoms, hopelessness and positive self-esteem. The analysis supports the notion that recovery and negative emotion are distinct but related constructs, each with a distinct set of predictors. Additionally, we found that gender was a significant predictor of recovery score over time, with men having lower recovery scores than women. Gender did not predict recovery scores at baseline, or negative emotion at either time point.

Comparison with previous research

Previous research has highlighted the importance of recovery as defined by the service user, which is often characterised by themes including hope, empowerment and social support. Reference Deegan4Reference Ridgeway8 Several qualitative research studies have been conducted including a service user-led study which revealed themes of rebuilding self, rebuilding life and hope for a better future as central to the recovery process. Reference Pitt, Kilbride, Nothard, Welford and Morrison5 A recent systematic review of recovery resulted in the ‘CHIME’ conceptual framework of recovery with five core processes: connectedness, hope, identity, meaning and empowerment. Reference Leamy, Bird, Le Boutillier, Williams and Slade24 Our study is consistent with previous studies that suggest a role for hope and self-esteem in personal recovery.

The findings from our longitudinal study replicate and extend those from cross-sectional studies. For example, Morrison et al assessed 122 individuals with experience of psychosis and found that personal recovery ratings were directly influenced by negative emotion and internal locus of control. Reference Morrison, Shyrane, Beck, Heffernan, Law and McCusker9 Positive symptoms and internal locus of control appeared to have an indirect effect of recovery mediated by negative emotion, which suggests that psychosocial factors were more directly related to personal recovery judgements than neuropsychiatric factors. Similarly, these findings are consistent with those that have examined the relationship between symptom remission, functioning and psychological factors over shorter moment-to-moment time frames. For example, a study that used an experience sampling method with 177 individuals with a diagnosis of schizophrenia found that negative affect was significantly related to symptom remission and functioning. Reference Oorschot, Lataster, Thewissen, Lardinois, van Os and Delespaul25 These results suggest that emotion – particularly negative emotion – may mediate the relationship between psychological and neuropsychiatric variables and recovery. Our study suggests a key role for negative emotion in predicting subjective recovery scores over more extended periods. Moreover, it supports previous research that suggests a key role for emotion in psychosis, Reference Garety, Kuipers, Fowler, Freeman and Bebbington26Reference Freeman and Garety28 and extends these findings in terms of their relevance for subjective recovery. The cognitive model of psychosis suggests that emotional changes occur within the context of psychotic experiences. Reference Garety, Kuipers, Fowler, Freeman and Bebbington26 These emotional changes can feed into the way psychotic experiences are processed and appraised, maintaining their occurrence. Reference Garety, Kuipers, Fowler, Freeman and Bebbington26 Further research has supported this claim that low mood, low self-esteem and anxiety contribute to the development and maintenance of psychosis. Reference Smith, Fowler, Freeman, Bebbington, Bashforth and Garety27,Reference Barrowclough, Tarrier, Humphreys, Ward, Gregg and Andrews29Reference Hartley, Barrowclough and Haddock31 Our findings suggest that emotion may mediate the relationship between experiences of psychosis and subjective recovery judgements. Negative emotion could contribute to the maintenance of psychosis, which will in turn affect the individual's quality of life, social functioning, hope and self-esteem, resulting in lower subjective recovery beliefs. Lower subjective recovery scores and recovery beliefs could be an additional perpetuating factor in psychosis.

Previous research suggests a role of gender in outcomes for people with a diagnosis of schizophrenia, finding that men generally have lower recovery expectations than women. Reference Goldstein, Tsuang and Faraone32 We found this to be the case at time 2 but not time 1. This finding is intriguing because it suggests that different processes may be at work shaping the development of recovery beliefs of men and women over time. Gender was not a predictor of negative emotion at either time point, suggesting that the relationship between recovery and gender was not mediated by negative emotion. It is possible that other processes may explain these differences; for example, sample selection might have played a part if men and women find their way into mental health services at different rates and at different stages of recovery. In addition, this research only explored demographic categories of male and female. Further research using a more sociocultural approach to examine gender roles and identity, reviewed by Nassar et al, Reference Nassar, Walders and Jankins33 in relation to recovery from psychosis may improve our understanding of the role of gender in both negative emotion and recovery.

Study strengths and weaknesses

The main strength of our study is its longitudinal design, allowing exploration of factors that may predict recovery. However, there are a number of methodological limitations. First, the study used a relatively modest sample size which was recruited by convenience sampling. Further research could study a larger sample, allowing for more extensive testing with more potential predictors and parameters. Second, the sample comprised mostly men and was diagnostically heterogeneous, which might mean that conceptualisations of recovery were very different within the sample. Similarly, information on length of illness was not collected for this data-set and this may have been an additional predictor of subjective recovery scores. However, the sample was recruited across a variety of services and settings to ensure it was representative of the target clinical population. Rates of attrition were low, with only three people not completing the 6-month follow-up assessment. However, only 110 participants completed all measures at both time points and were included in the final analysis. Additionally, because of the nature of the data used for this study (taken from a large research programme), it was not possible to describe fully the recruitment process in terms of numbers of participants approached at each stage for each study. Finally, although this study is one of the few to assess both neuropsychiatric and psychosocial factors that may predict recovery over time, the follow-up period was relatively short (6 months). Further research could examine the course of recovery and associated predictors over a longer time frame.

Future research examining the impact of insight on recovery judgements and on negative emotion would be beneficial. Previous research has suggested mixed results with regard to insight and recovery. For example, in one study improved insight was associated with improved outcomes, Reference Rosen and Garety34 whereas other studies have suggested that increased insight can be associated with increased negative outcomes including greater suicidality. Reference Kim, Jayathilake and Meltzer35 Developing an understanding of the role of insight in relation to recovery and negative emotion would be beneficial.

Implications for clinical practice

There are several potential implications of this research. Interventions that aim to reduce negative emotion while promoting self-esteem and hope may be beneficial to promoting recovery. Strategies such as improvement of self-esteem, Reference Hall and Tarrier36 and reduction of internalised stigma, Reference Lucksted, Drapalski, Calmes, Forbes, DeForge and Boyd37 for example, may lead to improved recovery outcomes. Cognitive–behavioural therapy (CBT) has been recommended in recent guidelines for the treatment and management of psychosis. 1 An editorial on the future of CBT highlighted the need for the approach to evolve in light of our advancing understanding of the role of emotion in psychosis. Reference Birchwood and Trower38 Our study supports this viewpoint, suggesting a key role for negative emotion in recovery outcomes, which should be addressed in future therapeutic intervention trials.

Interventions that aim to reduce the distress associated with experiences of psychosis and improve emotional processing may also be of benefit. A recent study piloted a brief intervention to reduce distress associated with persecutory delusions. Reference Foster, Startup, Potts and Freeman39,Reference Hepworth, Startup and Freeman40 The intervention emotional processing and metacognitive awareness (EPMA) was effective in reducing distress associated with delusions by enhancing the emotional processing of experiences. Reference Hepworth, Startup and Freeman40 It was suggested that worry might lead to distress by preventing emotional processing of upsetting experiences such as delusions. Consideration of other factors that might reduce distress surrounding experiences of psychosis should also be considered. For example, a current trial is investigating the impact of sleep on psychosis using a cognitive–behavioural intervention for insomnia. Reference Freeman, Startup, Myers, Harvey, Geddes and Yu41 Early pilot studies of this approach have indicated improvements in sleep, as well as reduction in delusions, anomalies of experience, anxiety and depression. Reference Myers, Startup and Freeman42 Emphasis in services should expand from purely symptom- and functioning-based approaches towards a more psychosocial approach, taking into account the key role of negative emotion on personal recovery outcomes.

Footnotes

Declaration of interest

None.

References

1 National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults: Treatment and Management (NICE clinical guideline CG178). NICE, 2014.Google Scholar
2 Torgalsboen, AK. Full recovery from schizophrenia: the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender. Psychiatr Res 1999; 88: 143–52.CrossRefGoogle ScholarPubMed
3 Bellack, A. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull 2006; 32: 432–42.Google ScholarPubMed
4 Deegan, PE. Recovery: the lived experience of rehabilitation. Psychosoc Rehabil J 1988; 11: 11–9.Google Scholar
5 Pitt, L, Kilbride, M, Nothard, S, Welford, M, Morrison, AP. Researching recovery from psychosis: a user-led project. Psychiatr Bull 2007; 31: 5560.CrossRefGoogle Scholar
6 Leete, E. How I perceive and manage my illness. Schizophr Bull 1989; 15: 197200.CrossRefGoogle Scholar
7 Mead, S, Copeland, ME. What recovery means to us: consumers' perspectives. Community Ment Health J 2000; 36: 315–28.CrossRefGoogle ScholarPubMed
8 Ridgeway, P. Restoring psychiatric disability: learning from first person recovery narratives. Psychiatr Rehab J 2001; 24: 335–43.Google Scholar
9 Morrison, AP, Shyrane, N, Beck, R, Heffernan, S, Law, H, McCusker, M, et al. Psychosocial and neuropsychiatric predictors of subjective recovery from psychosis. Psychiatr Res 2013; 208: 203–9.CrossRefGoogle ScholarPubMed
10 Neil, ST, Kilbride, M, Pitt, L, Nothard, S, Welford, M, Sellwood, W, et al. The questionnaire about the process of recovery (QPR): a measurement tool developed in collaboration with service users. Psychosis 2009; 1: 145–55.CrossRefGoogle Scholar
11 Law, H, Neil, ST, Dunn, G, Morrison, AP. Psychometric properties of the Questionnaire about the Process of Recovery (QPR). Schizophr Res 2014; 156: 184–9.CrossRefGoogle ScholarPubMed
12 Kay, SR, Fiszbein, A, Opler, LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–76.CrossRefGoogle ScholarPubMed
13 Kay, SR, Opler, LA, Lindenmayer, JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatr Res 1988; 23: 99110.CrossRefGoogle ScholarPubMed
14 Morosini, PL, Magliano, L, Brambilla, L, Ugolini, S, Pioli, R. Development, reliability and acceptability of a new version of the DSM-IV Social Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000; 101: 323–9.Google ScholarPubMed
15 Kawata, AK, Revicki, DA. Psychometric properties of the Personal and Social Performance scale (PSP) among individuals with schizophrenia living in the community. Qual Life Res 2008; 17: 1247–56.CrossRefGoogle ScholarPubMed
16 Hall, RCW. Global assessment of functioning: a modified scale. Psychosomatics 1995; 36: 267–75.Google ScholarPubMed
17 Addington, D, Addington, J, Schissel, B. A depression rating scale for schizophrenics. Schizophr Res 1990; 3: 247–51.CrossRefGoogle ScholarPubMed
18 Beck, AT, Weissman, A, Lester, D, Trexler, L. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol 1974; 42: 861–5.CrossRefGoogle ScholarPubMed
19 Nunn, KP, Lewin, TJ, Walton, M, Carr, VJ. The construction and characteristics of an instrument to measure personal hopefulness. Psychol Med 1996; 26: 531–45.CrossRefGoogle ScholarPubMed
20 Dyce, JA. Factor structure of the Beck Hopelessness Scale. J Clin Psychol 1996; 52: 555–8.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
21 Young, MA, Halper, IS, Clark, DC, Scheftner, W, Fawcett, J. An item-response theory evaluation of the Beck Hopelessness Scale. Cogn Ther Res 1992; 16: 579–87.CrossRefGoogle Scholar
22 Lecomte, T, Corbiere, M, Laisne, F. Investigating self-esteem in individuals with schizophrenia: relevance of the self-esteem rating scale–short form. Psychiatr Res 2006; 143: 99108.CrossRefGoogle ScholarPubMed
23 Juckel, G, Morosini, PL. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry 2008; 21: 630–9.CrossRefGoogle ScholarPubMed
24 Leamy, M, Bird, V, Le Boutillier, C, Williams, J, Slade, M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry 2011; 199: 445–52.CrossRefGoogle ScholarPubMed
25 Oorschot, M, Lataster, T, Thewissen, V, Lardinois, M, van Os, J, Delespaul, PAEG, et al. Symptomatic remission in psychosis and real-life functioning. Br J Psychiatry 2012; 201: 215–20.CrossRefGoogle ScholarPubMed
26 Garety, PA, Kuipers, E, Fowler, D, Freeman, D, Bebbington, PE. A cognitive model of the positive symptoms of psychosis. Psychol Med 2001; 31: 189–95.CrossRefGoogle ScholarPubMed
27 Smith, B, Fowler, DG, Freeman, D, Bebbington, P, Bashforth, H, Garety, P, et al. Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophr Res 2006; 86: 181–8.CrossRefGoogle ScholarPubMed
28 Freeman, D, Garety, PA. Connecting neurosis and psychosis: the direct influence of emotion on delusions and hallucinations. Behav Res Ther 2003; 41: 923–47.CrossRefGoogle ScholarPubMed
29 Barrowclough, C, Tarrier, N, Humphreys, L, Ward, J, Gregg, L, Andrews, B. Self-esteem in schizophrenia: relationships between self-evaluation, family attitudes, and symptomatology. J Abnorm Psychol 2003; 112: 92–9.CrossRefGoogle ScholarPubMed
30 Krabbendam, L, Myin-Germeys, I, Hanssen, M, de Graaf, R, Vollebergh, W, Bak, M, et al. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br J Clin Psychol 2005; 44: 113–25.CrossRefGoogle ScholarPubMed
31 Hartley, S, Barrowclough, C, Haddock, G. Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms. Acta Psychiatr Scand 2013; 128: 327–46.CrossRefGoogle ScholarPubMed
32 Goldstein, JM, Tsuang, MT, Faraone, SV. Gender and schizophrenia: implications for understanding the heterogeneity of the illness. Psychiatr Res 1989; 28: 243–53.CrossRefGoogle ScholarPubMed
33 Nassar, EH, Walders, N, Jankins, JH. The experience of schizophrenia: what's gender got to do with it? A critical review of the current status of research on schizophrenia. Schizophr Bull 2002; 28: 351–62.CrossRefGoogle Scholar
34 Rosen, K, Garety, P. Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophr Bull 2005; 31: 735–50.CrossRefGoogle ScholarPubMed
35 Kim, CH, Jayathilake, K, Meltzer, HY. Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophr Res 2003; 60: 7180.CrossRefGoogle ScholarPubMed
36 Hall, PL, Tarrier, N. The cognitive–behavioural treatment of low self-esteem in psychotic patients: a pilot study. Behav Res Ther 2003; 41: 317–32.CrossRefGoogle ScholarPubMed
37 Lucksted, A, Drapalski, A, Calmes, C, Forbes, C, DeForge, B, Boyd, J. Ending self-stigma: pilot evaluation of a new intervention to reduce internalized stigma among people with mental illnesses. Psychiatr Rehab J 2011; 35: 51–4.CrossRefGoogle ScholarPubMed
38 Birchwood, MJ, Trower, P. The future of cognitive–behavioural therapy for psychosis: not a quasi-neuroleptic. Br J Psychiatry 2006; 188: 107–8.CrossRefGoogle Scholar
39 Foster, C, Startup, H, Potts, L, Freeman, D. A randomised controlled trial of a worry intervention for individuals with persistent persecutory delusions. J Behav Ther Exp Psychiatry 2010; 41: 4551.CrossRefGoogle ScholarPubMed
40 Hepworth, C, Startup, H, Freeman, D. Developing treatments of persistent persecutory delusions: the impact of an emotional processing and metacognitive awareness intervention. J Nerv Ment Dis 2011; 199: 653–8.CrossRefGoogle ScholarPubMed
41 Freeman, D, Startup, H, Myers, E, Harvey, A, Geddes, J, Yu, LM, et al. The effects of using cognitive behavioural therapy to improve sleep for patients with delusions and hallucinations (the BEST study): study protocol for a randomized controlled trial. Trials 2013; 14: 214.CrossRefGoogle ScholarPubMed
42 Myers, E, Startup, H, Freeman, D. Cognitive behavioural treatment of insomnia in individuals with persistent persecutory delusions. J Behav Ther Exp Psychiatry 2011; 42: 330–6.CrossRefGoogle ScholarPubMed
Figure 0

Table 1 Participant characteristics (n = 110)

Figure 1

Table 2 Participant scores for key measures at baseline and 6-month follow-up

Figure 2

Fig. 1 Path diagram of core model (model 1) showing standardised regression coefficients (bold type indicates significance at P<0.05).Rec, recovery; Nemo, negative emotion; suffix indicates time 1 or 2.

Figure 3

Table 3 Parameter estimates for core model of recovery and negative emotion (n = 110)

Figure 4

Fig. 2 Path diagram of model 2.5, showing standardised regression coefficients (bold type indicates significance at P<0.05).Func, functioning; Hope, hopelessness; Nemo, negative emotion; PANSS, Positive and Negative Syndrome Scale; Rec, recovery; SE, self-esteem (suffix indicates time 1 or time 2).

Figure 5

Table 4 Parameter estimates for full model (model 2.5) (n = 110)

Supplementary material: PDF

Law et al. supplementary material

Supplementary Table S1-S3

Download Law et al. supplementary material(PDF)
PDF 98.3 KB
Submit a response

eLetters

No eLetters have been published for this article.